English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 906227      Online Users : 813
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    Siblings
    Books/Book Section [1/1]
    Periodical Articles [327/330]

    Collection Statistics

    Item counts issued in 3 years:16(8.94%)
    Items With Fulltext:115(64.25%)

    Download counts of the item
    Download times greater than 0:115(100.00%)
    Download times greater than 100:112(97.39%)
    Total Bitstream Download Counts:39325(22.06%)

    Last Update: 2024-12-01 10:20


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 126-150 of 179. (8 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2013-05 Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
    2013-03 Auy922, a novel Hsp90 inhibitor effective against ABC-dlbcl and malt lymphoma cells harboring genetic alteration-associated NF-kappa B activation Annals of Oncology. 2013 Mar;24(Suppl. 1):24-25.
    2012-11 Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells European Journal of Cancer. 2012 Nov;48(Suppl. 6):48.
    2012-10 Front-line antibiotic therapy in early-stage H. Pylori-positive gastric Diffuse Large B-Cell Lymphomas with or without malt features Annals of Oncology. 2012 Oct;23(Suppl. 11):105.
    2012-09 Heat shock protein 90 inhibition downregulates c-Kit expression in gist cells through diminishing transcription and enhancing protein degradation via both autophagy and proteasome pathways Annals of Oncology. 2012 Sep;23(Suppl. 9):538.
    2012-09 Detection of caga expression in gastric mucosa-associated lymphoid tissue lymphoma-biologic significance and clinical implication Annals of Oncology. 2012 Sep;23(Suppl. 9):351.
    2012-05-20 Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial Journal of Clinical Oncology. 2012 May 20;30(15 Suppl.):Abstract number TPS4149.
    2012-03 Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells Annals of Oncology. 2012 Mar;23(Suppl. 1):28.
    2012-02 Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy Journal of Clinical Oncology. 2012 Feb;30(4):613.
    2011-11 Role of chromogranin a and neuron-specific enolase biomarkers in progression-free survival (PFS) with everolimus (EVE) versus placebo (PB) in patients with advanced pancreatic neuroendocrine tumors (pNET): Phase III radiant-3 results Neuroendocrinology. 2011 Nov;94(Suppl. 1):37.
    2011-09 B cell-activating factor of TNF family (BAFF) signaling pathway is associated with Helicobacter Pylori-independent growth of gastric MALT lymphoma without T(11;18)(q21;q21) European Journal of Cancer. 2011 Sep;47(Suppl 1):S648-S649.
    2011-09 Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers European Journal of Cancer. 2011 Sep;47(Suppl 1):S467.
    2011-05 Novel Hsp90 inhibitor NVP-AUY922 downregulates mutant c-Kit protein through transcription and enhancing protein degradation via both proteasome and autophagy-mediated pathways Drug Metabolism Reviews. 2011 May;43(Suppl. 1):78-79.
    2011-04 Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas Cancer Research. 2011 Apr;71:Abstract number 1701.
    2011-02 Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications Laboratory Investigation. 2011 Feb;91:17A.
    2011-02 Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications Modern Pathology. 2011 Feb;24(Suppl. 1):17A-18A.
    2011-02 A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 237.
    2011-02 Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 86.
    2011-02 Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4 ):Abstract Number 6
    2011-02 Effect of inhibition of heat-shock protein 90 on mutant c-Kit protein as modulated by mRNA expression and protein degradation through both proteasome and autophagy-mediated pathways Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4):Abstract Number 54
    2010-11 Medical resources utilization of five most prevalent cancers in Taiwan (lung cancer, liver cancer, colorectal cancer, gastric cancer, and brest cancer): 2001 similar to 2007 Value in Health. 2010 Nov;13(7):A279.
    2010-10 Nilotinib and sorafenib are more potent inhibitors for exon 11/17 C-kit mutants than sunitinib: results of incorporating cell-based screening platform and virtual molecular modeling study Annals of Oncology. 2010 Oct;21(Suppl. 8):56-56.
    2010-10 Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma Annals of Oncology. 2010 Oct;21(Suppl. 8):52.
    2010-06 Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
    2010-05 Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024.

    Showing items 126-150 of 179. (8 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback